ArticleResearch square2025
Comparative Analysis of Deep Mutational Scanning Datasets in Enteroviruses A and B Identifies Functional Divergence and Therapeutic Targets.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
5 authors.
Funding
Abstract
Deep mutational scanning (DMS) can define functional constraints acting on viral proteomes by quantifying the effects of mutations on viral fitness. However, DMS analyses do not discern type-specific from species-level constraints, limiting their utility in understanding how selective pressures change as viral families diversify. Here, we show that comparison of DMS datasets from related viruses can overcome these limitations. By contrasting two proteome-wide DMS datasets from prototypical members of the enterovirus A and B species, we identify evolutionary constraints at the species level to occur across core enzymatic machinery and capsid assembly interfaces. In contrast, type-level constraints are observed across host-interaction sites in both structural and non-structural proteins. Furthermore, we find DMS data to reflect both type- and species-level evolutionary signatures in nature yet diverge at conserved hotspots subjected to selection pressures that are lacking in vitro. Finally, we highlight the utility of comparative DMS studies for drug discovery by identifying a novel, mutationally constrained pocket in the 2C helicase that is conserved across all major human enterovirus species. Collectively, our findings provide a framework for dissecting evolutionary pressures acting at different evolutionary scales and for guiding the rational design of broad-spectrum therapeutics with high barriers to resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.